Concepedia

Author

Santiago Thibaud

Icahn School of Medicine at Mount SinaiORCID

Also Known As

Santiago Thibaud

135

Publications

1K

Citations

15

H-Index

33

Concepts

All Affiliations

Icahn School of Medicine at Mount SinaiTisch HospitalMemorial Sloan Kettering Cancer CenterTisch Cancer InstituteUniversity Health Network
ST

About

Santiago Thibaud is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, immunology, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

201

2

Health Sciences

4

4

87

3

Cellular Therapies

1

1

97

4

Diabetes

1

1

15

5

Epidemiology

1

1

15

Santiago Thibaud

×

16

Publications

658

Citations

14

H-Index

YearCitations

Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19

Leonard Naymagon, Nicole Zubizarreta, Jonathan Feld,

Thrombosis Research

2020

129

IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Guido Lancman, Kian Parsa, Krzysztof Kotlarz,

Blood Cancer Discovery

2023

100

Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy

Oliver Van Oekelen, Karthik Nath, Tarek H. Mouhieddine,

Blood

2022

97

Ferritin levels in patients with COVID‐19: A poor predictor of mortality and hemophagocytic lymphohistiocytosis

Jonathan Feld, Douglas Tremblay, Santiago Thibaud,

International Journal of Laboratory Hematology

2020

93

Infections and Severe Hypogammaglobulinemia in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies

Guido Lancman, Kian Parsa, Cesar Rodriguez,

Blood

2022

39

Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma

Tarek H. Mouhieddine, Oliver Van Oekelen, David T. Melnekoff,

Blood Advances

2022

37

Comprehensive Characterization of Prolonged Unexplained Cytopenias in Relapsed/Refractory Multiple Myeloma Patients Following BCMA-Directed CAR-T Cell Therapy

Santiago Thibaud, Md. Babu Mia, Oliver Van Oekelen,

Blood

2022

25

POEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter Analysis

Artur Jurczyszyn, Jorge J. Castillo, Magdalena Olszewska‐Szopa,

Clinical Lymphoma Myeloma & Leukemia

2021

20

Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma

Mateo Mejía Saldarriaga, Darren Pan, Caitlin Unkenholz,

Blood Advances

2024

20

HIV portends a poor prognosis in myelodysplastic syndromes

Justin D. Kaner, Santiago Thibaud, Sakshi Jasra,

Leukemia & lymphoma/Leukemia and lymphoma

2019

17

Page 1